CTRI/2012/08/002847已完成未知
The effect of food on the pharmacokinetics of metformin given either as metformin hydrochloride SR 1000mg tablet or as a fixed dose combination of metformin hydrochloride SR 1000mg/glimepiride 2mg tablet in healthy Indian volunteers.
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Ba/be
入排标准
入选标准
- •1.Healthy as determined by a responsible and experienced physician, based on a medical evaluation including medical history, physical examination, laboratory tests, 12 lead ECG and chest x ray. A subject with a clinical abnormality or laboratory parameters outside the reference range for the population being studied may be included only if the Medical Investigator agrees that the finding is unlikely to introduce additional risk factors and will not interfere with the study procedures.
- •2.Males between 18 and 50 years of age (both inclusive), who are willing to participate in the study and provide a written signed and dated informed consent.
- •3.Body weight more than or equal to 60 kg and BMI within the range 18.5-24.9 kg/m2 (inclusive).
- •4.Availability of a study volunteer for the entire study period and willingness to adhere to protocol requirements as evidenced by written informed consent.
排除标准
- •1.A positive pre-study urine drug screen.
- •2.A positive test for HIV antibody.
- •3.Subject has clinically significant abnormal values of laboratory parameters.
- •4.Regular alcohol consumption within 6 months of the study defined as an average weekly intake of more than 21 units. One unit is equivalent to 8 g of alcohol a half-pint (approximate 240 mL) of beer, 1 glass (125 mL) of wine or 1 (25 mL) measure of spirits (CTRI, 2010).
- •5.The subject has participated in a clinical trial and has received an investigational product within the following time period prior to the first dosing day in the current study: 30 days, 5 half-lives or twice the duration of the biological effect of the investigational product (whichever is longer).
- •6.Exposure to more than four new chemical entities within 12 months prior to the first dosing day.
- •7.Unable to refrain from the use of prescription or non-prescription drugs, including vitamins, herbal and dietary supplements (including St Johnâ??s Wort) within 7 days (or 14 days if the drug is a potential enzyme inducer) or 5 half-lives (whichever is longer) prior to the first dose of study medication, unless in the opinion of the Investigator the medication will not interfere with the study procedures or compromise subject safety.
- •8.History of sensitivity to any of the study medications, or components thereof or a history of drug or other allergy that, in the opinion of the investigator contraindicates their participation.
- •9.Where participation in another study would result in donation of blood or blood products in excess of 350 ml within a 90 day period prior to this study.
- •10.Unwillingness or inability to follow the procedures outlined in the protocol.
- •11.Subject is mentally or legally incapacitated or the subject is incapable of understanding the informed consent.
- •12.Subject has any evidence of impaired renal, hepatic, cardiac, lung or gastrointestinal function. Study volunteers with a history of tuberculosis, epilepsy, asthma (during past 5 years), diabetes, psychosis or glaucoma will not be eligible for the study.
- •13.History of sensitivity to heparin or heparin-induced thrombocytopenia.
- •14.Regular use of tobacco or nicotine containing products within 6 months prior to screening.
- •15.Subject is intolerant to venipuncture.
- •16.Unable to refrain from consumption of red wine, seville oranges, grapefruit or grapefruit juice [andor pummelos, exotic citrus fruits, grapefruit hybrids or fruit juices] from 7 days prior to the first dose of study medication
研究者
相似试验
已完成
1 期
The effect of food on the pharmacokinetcs, tolerability and pharmacodynamics of BNC210 in healthy male volunteersGeneralised Anxiety DisorderMental Health - AnxietyACTRN12610000442000Bionomics Limited4
进行中（未招募）
1 期
Effect of food on the pharmacokinetic profile of saquinavir at steady state in HIV-infected patients treated with saquinavir/ritonavir 1000/100 mg b.i.d. - Saquinavir food pharmacokinetic studyEUCTR2005-004430-41-GBSt Stephen's AIDS Trust24
招募中
Unknown
In vivo Bioequivalence study of Metformin tabletIRCT20220211053992N26Tabriz University of Medical Sciences24
进行中（未招募）
不适用
Invloed van voeding op farmacokinetiek en -dynamiek van desmopressine tablet in vergelijking met desmopressine MELT-vormKinderen met Monosymptomatische Enuresis Nocturna en nachtelijke polyurieEUCTR2009-017265-33-BEniversity Hospital Ghent
已完成
不适用
Pilot study of food effect on pharmacokinetics of STROMECTOL in scabies patients.scabiesJPRN-UMIN000006789aboratory of medical safety management, Tokyo University of Science12